BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30957331)

  • 1. Pneumocystis jirovecii pneumonia: A potential complication of sirolimus therapy.
    Shetty AK
    J Paediatr Child Health; 2019 Apr; 55(4):484. PubMed ID: 30957331
    [No Abstract]   [Full Text] [Related]  

  • 2.
    Russell TB; Rinker EK; Dillingham CS; Givner LB; McLean TW
    Pediatrics; 2018 Apr; 141(Suppl 5):S421-S424. PubMed ID: 29610164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon in an infant: Successful treatment with prednisolone, vincristine, and addition of sirolimus.
    Cashell J; Smink GM; Helm K; Xavier F
    Pediatr Blood Cancer; 2018 Dec; 65(12):e27305. PubMed ID: 30070028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of Kaposiform hemangioendothelioma with everolimus.
    Uno T; Ito S; Nakazawa A; Miyazaki O; Mori T; Terashima K
    Pediatr Blood Cancer; 2015 Mar; 62(3):536-8. PubMed ID: 25306933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low dose sirolimus treatment for refractory tufted angioma and congenital kaposiform hemangioendothelioma, both with Kasabach-Merritt phenomenon.
    Mariani LG; Schmitt IR; Garcia CD; Kiszewski AE
    Pediatr Blood Cancer; 2019 Aug; 66(8):e27810. PubMed ID: 31087627
    [No Abstract]   [Full Text] [Related]  

  • 6. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: from vincristine to sirolimus.
    Jahnel J; Lackner H; Reiterer F; Urlesberger B; Urban C
    Klin Padiatr; 2012 Oct; 224(6):395-7. PubMed ID: 23070861
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful Management of Pancreatic Kaposiform Hemangioendothelioma With Sirolimus: Case Report and Literature Review.
    Wang C; Li Y; Xiang B; Li F; Chen S; Li L; Ji Y
    Pancreas; 2017; 46(5):e39-e41. PubMed ID: 28426496
    [No Abstract]   [Full Text] [Related]  

  • 8. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: successful treatment with vincristine and ticlopidine.
    Barabash-Neila R; García-Rodríguez E; Bernabeu-Wittel J; Bueno-Rodríguez I; Ramírez-Villar G; López-Gutierrez JC
    Indian J Pediatr; 2012 Oct; 79(10):1386-7. PubMed ID: 22161581
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of Refractory Pediatric Kaposiform Hemangioendothelioma With Sirolimus and Aspirin.
    MacFarland SP; Sullivan LM; States LJ; Bailey LC; Balamuth NJ; Womer RB; Olson TS
    J Pediatr Hematol Oncol; 2018 May; 40(4):e239-e242. PubMed ID: 29240034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Image Gallery: Kaposiform haemangioendothelioma.
    Moscarella E; Ametrano O; Diplomatico M; De Chiara C; Capasso M; Errico ME; Picciocchi R
    Br J Dermatol; 2017 Jun; 176(6):e124. PubMed ID: 28581217
    [No Abstract]   [Full Text] [Related]  

  • 11. Sirolimus for treatment of Kaposiform haemangioendothelioma with Kasabach-Merritt phenomenon: a retrospective cohort study.
    Zhang G; Chen H; Gao Y; Liu Y; Wang J; Liu XY
    Br J Dermatol; 2018 May; 178(5):1213-1214. PubMed ID: 29388191
    [No Abstract]   [Full Text] [Related]  

  • 12. First Intracardiac Kaposiform Hemangioendothelioma in an Infant Resolved With Sirolimus: A Case Report.
    Zaidi SJ; Shaik S; Agrawal C; Cossor W
    J Pediatr Hematol Oncol; 2018 Oct; 40(7):536-540. PubMed ID: 30067556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kaposiform haemangioendothelioma in an adult: lack of response to topical sirolimus and response to radiotherapy.
    Der Sarkissian SA; Wong XL; Kossard S; Hong A; Sebaratnam DF
    Clin Exp Dermatol; 2022 Jan; 47(1):192-193. PubMed ID: 34480811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of Kasabach-Merritt syndrome arising from kaposiform hemangioendothelioma by systemic corticosteroid therapy and surgery.
    Jiang RS; Hu R
    Int J Clin Oncol; 2012 Oct; 17(5):512-6. PubMed ID: 21947597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comment on: Steroid-resistant kaposiform hemangioendothelioma: A retrospective study of 37 patients treated with vincristine and long-term follow-up.
    Adams DM; Hammill AM; Mobberley-Schuman PS; Trenor CC
    Pediatr Blood Cancer; 2015 Nov; 62(11):2056. PubMed ID: 26052679
    [No Abstract]   [Full Text] [Related]  

  • 16. Sirolimus for Kaposiform Hemangioendothelioma With Kasabach-Merritt Phenomenon in Two Infants.
    Wang Y; Kong L; Sun B; Cui J; Shen W
    J Craniofac Surg; 2020 Jun; 31(4):1074-1077. PubMed ID: 32176003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kaposiform hemangioendothelioma: therapeutic efficacy for an enigmatic diagnosis.
    Blei F
    Pediatr Blood Cancer; 2015 Apr; 62(4):551-2. PubMed ID: 25559734
    [No Abstract]   [Full Text] [Related]  

  • 18. Vincristine and sirolimus in the treatment of kaposiform haemangioendothelioma.
    Peng S; Yang K; Xu Z; Chen S; Ji Y
    J Paediatr Child Health; 2019 Sep; 55(9):1119-1124. PubMed ID: 30604513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sirolimus therapy for kaposiform hemangioendothelioma with long-term follow-up.
    Wang Z; Yao W; Sun H; Dong K; Ma Y; Chen L; Zheng S; Li K
    J Dermatol; 2019 Nov; 46(11):956-961. PubMed ID: 31489702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steroid-resistant kaposiform hemangioendothelioma: a retrospective study of 37 patients treated with vincristine and long-term follow-up.
    Wang Z; Li K; Yao W; Dong K; Xiao X; Zheng S
    Pediatr Blood Cancer; 2015 Apr; 62(4):577-80. PubMed ID: 25346262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.